66 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength https://seekingalpha.com/article/4661586-cvs-shares-remain-modestly-undervalued-robust-free-cash-flow-technical-strength?source=feed_all_articles Jan 07, 2024 - CVS Health has strong earnings, valuation, dividend, and free cash flow forecasts. Click here to read why I reiterate my Buy rating on CVS stock.
Top Analyst Reports for Merck, Salesforce & Philip Morris https://www.zacks.com/commentary/2206306/top-analyst-reports-for-merck-salesforce-philip-morris?cid=CS-ZC-FT-research_daily-2206306 Jan 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
3 Retail Pharmacy & Drugstore Stocks to Watch Amid Industry Headwinds https://www.zacks.com/commentary/2206233/3-retail-pharmacy-drugstore-stocks-to-watch-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2206233 Jan 05, 2024 - Zacks Retail-Pharmacies and Drug Stores industry players like CVS, HLF and RADCQ are likely to gain despite reimbursement challenges that are hurting the overall industry health.
Here's Why CVS Health (CVS) Fell More Than Broader Market https://www.zacks.com/stock/news/2205902/here-s-why-cvs-health-cvs-fell-more-than-broader-market?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205902 Jan 04, 2024 - CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know https://www.zacks.com/stock/news/2205591/cvs-health-corporation-cvs-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2205591 Jan 04, 2024 - Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS to drop Humira from certain formularies, cover biosimilars instead https://seekingalpha.com/news/4052170-cvs-to-drop-humira-from-certain-formularies-cover-biosimilars-instead?source=feed_sector_healthcare Jan 03, 2024 - CVS Health (CVS) said that its Caremark unit will remove AbbVie’s (ABBV) blockbuster drug Humira from its major national commercial formularies on April 1 and c
CVS Health (CVS) Stock Moves -0.01%: What You Should Know https://www.zacks.com/stock/news/2203894/cvs-health-cvs-stock-moves-0-01-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2203894 Dec 29, 2023 - CVS Health (CVS) closed the most recent trading day at $78.96, moving -0.01% from the previous trading session.
Here's Why You Should Retain CVS Health (CVS) Stock for Now https://www.zacks.com/stock/news/2202694/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202694 Dec 27, 2023 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
Here are the big health sector themes to watch next year https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html Dec 22, 2023 - The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024.
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing https://www.zacks.com/stock/news/2201251/cvs-health-cvs-surpasses-market-returns-some-facts-worth-knowing?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2201251 Dec 21, 2023 - In the closing of the recent trading day, CVS Health (CVS) stood at $78.62, denoting a +1.79% change from the preceding trading day.

Pages: 1234567

<<<Page 5>